ArticleGland surgery2022

Combined targeting of KRT23 and NCCRP1 as a potential novel therapeutic approach for the treatment of triple-negative breast cancer.

Jian Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.